Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Condition: Pediatric Recurrent Brain Tumor Interventions: Biological: Personalized neoantigen DNA vaccine; Device: TDS-IM System; Procedure: Peripheral blood draw Sponsors: Washington University School of Medicine; Children's Discovery Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Children | Neurology | Pediatrics | Research | Vaccines